Join to View Full Profile
33 Whiting Hill RoadEastern Maine Medical CenterBrewer, ME 04412
Phone+1 207-973-7478
Fax+1 207-973-7807
Dr. Maegawa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2008 - 2011
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2005 - 2008
Federal University of Parana Faculty of MedicineClass of 2005
Certifications & Licensure
ME State Medical License 2012 - 2026
CA State Medical License 2011 - 2025
NJ State Medical License 2020 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsMolecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis.Jerald P Radich, Matthew Wall, Susan Branford, Catarina D Campbell, Shalini Chaturvedi
Haematologica. 2023-06-01 - Therapy for patients with chronic phase-chronic myeloid leukemia previously treated with ⩾2 tyrosine kinase inhibitors: a systematic literature review.Ehab Atallah, Lovneet Saini, Rodrigo Maegawa, Tanvi Rajput, Regina Corbin
Therapeutic Advances in Hematology. 2023-01-01 - 1 citationsChronic Myeloid Leukemia: Part II-Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Pers...Ehab L Atallah, Rodrigo Maegawa, Dominick Latremouille-Viau, Carmine Rossi, Annie Guérin
Journal of Health Economics and Outcomes Research. 2022-01-01
Lectures
- Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- A Phase II Study of the Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone (RVD) Combination Therapy for Patients with Newly Diagnosed Mult...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Maine Patients and Researchers Fighting Cancer – Part 1February 2nd, 2017- Maine Patients and Researchers Fighting Cancer – Part 2February 2nd, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
